Annual Working Capital
-$15.14 M
+$615.30 K+3.91%
September 30, 2024
Summary
- As of February 12, 2025, OTLK annual working capital is -$15.14 million, with the most recent change of +$615.30 thousand (+3.91%) on September 30, 2024.
- During the last 3 years, OTLK annual working capital has fallen by -$29.89 million (-202.59%).
- OTLK annual working capital is now -202.59% below its all-time high of $14.76 million, reached on September 30, 2021.
Performance
OTLK Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$15.14 M
-$18.20 M-594.08%
September 30, 2024
Summary
- As of February 12, 2025, OTLK quarterly working capital is -$15.14 million, with the most recent change of -$18.20 million (-594.08%) on September 30, 2024.
- Over the past year, OTLK quarterly working capital has increased by +$10.44 million (+40.82%).
- OTLK quarterly working capital is now -126.32% below its all-time high of $57.52 million, reached on December 31, 2021.
Performance
OTLK Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
OTLK Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.9% | +40.8% |
| 3 y3 years | -202.6% | -202.6% |
| 5 y5 years | -123.0% | -6.5% |
OTLK Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -202.6% | +3.9% | -126.3% | +40.8% |
| 5 y | 5-year | -202.6% | +3.9% | -126.3% | +40.8% |
| alltime | all time | -202.6% | +47.3% | -126.3% | +60.3% |
Outlook Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | -$15.14 M(-3.9%) | -$15.14 M(-594.1%) |
| Jun 2024 | - | $3.06 M(-17.3%) |
| Mar 2024 | - | $3.71 M(-114.5%) |
| Dec 2023 | - | -$25.58 M(+62.4%) |
| Sep 2023 | -$15.75 M(-302.2%) | -$15.75 M(+127.9%) |
| Jun 2023 | - | -$6.91 M(-172.6%) |
| Mar 2023 | - | $9.52 M(-79.6%) |
| Dec 2022 | - | $46.59 M(+498.1%) |
| Sep 2022 | $7.79 M(-47.2%) | $7.79 M(-59.2%) |
| Jun 2022 | - | $19.08 M(-45.7%) |
| Mar 2022 | - | $35.14 M(-38.9%) |
| Dec 2021 | - | $57.52 M(+289.8%) |
| Sep 2021 | $14.76 M(+618.0%) | $14.76 M(+20.4%) |
| Jun 2021 | - | $12.26 M(-38.4%) |
| Mar 2021 | - | $19.89 M(-1921.9%) |
| Dec 2020 | - | -$1.09 M(-153.1%) |
| Sep 2020 | $2.06 M | $2.06 M(-79.0%) |
| Jun 2020 | - | $9.78 M(-168.8%) |
| Mar 2020 | - | -$14.22 M(+4.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | - | -$13.56 M(+99.7%) |
| Sep 2019 | -$6.79 M(-76.4%) | -$6.79 M(+54.0%) |
| Jun 2019 | - | -$4.41 M(-82.3%) |
| Mar 2019 | - | -$24.86 M(-1.5%) |
| Dec 2018 | - | -$25.23 M(-12.2%) |
| Sep 2018 | -$28.74 M(+15.7%) | -$28.74 M(+50.2%) |
| Jun 2018 | - | -$19.13 M(-23.0%) |
| Mar 2018 | - | -$24.83 M(+56.7%) |
| Dec 2017 | - | -$15.85 M(-36.2%) |
| Sep 2017 | -$24.83 M(+68.3%) | -$24.83 M(-34.8%) |
| Jun 2017 | - | -$38.08 M(+12.3%) |
| Mar 2017 | - | -$33.92 M(+17.2%) |
| Dec 2016 | - | -$28.95 M(+96.2%) |
| Sep 2016 | -$14.76 M(-32.5%) | -$14.76 M(+82.8%) |
| Jun 2016 | - | -$8.08 M(-74.7%) |
| Mar 2016 | - | -$31.87 M(+41.3%) |
| Dec 2015 | - | -$22.56 M(+3.1%) |
| Sep 2015 | -$21.88 M(0.0%) | -$21.88 M |
| Sep 2014 | -$21.88 M | - |
FAQ
- What is Outlook Therapeutics annual working capital?
- What is the all time high annual working capital for Outlook Therapeutics?
- What is Outlook Therapeutics annual working capital year-on-year change?
- What is Outlook Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly working capital year-on-year change?
What is Outlook Therapeutics annual working capital?
The current annual working capital of OTLK is -$15.14 M
What is the all time high annual working capital for Outlook Therapeutics?
Outlook Therapeutics all-time high annual working capital is $14.76 M
What is Outlook Therapeutics annual working capital year-on-year change?
Over the past year, OTLK annual working capital has changed by +$615.30 K (+3.91%)
What is Outlook Therapeutics quarterly working capital?
The current quarterly working capital of OTLK is -$15.14 M
What is the all time high quarterly working capital for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly working capital is $57.52 M
What is Outlook Therapeutics quarterly working capital year-on-year change?
Over the past year, OTLK quarterly working capital has changed by +$10.44 M (+40.82%)